Literature DB >> 1709334

Chemistry and biology of alpha-fetoprotein.

H F Deutsch1.   

Abstract

Alpha-Fetoprotein (AFP) is a product of specific fetal tissues and of neoplastic cells of hepatocyte or germ cell origin in adults. This protein belongs to a gene family that is phylogenetically most closely related to serum albumin. Its primary, secondary, and tertiary structural aspects appear similar to the three-domain concept proposed for the latter protein. The primary sequence of AFP departs most widely from serum albumin in the first 135 amino acid residues, with about 42% of the remaining 590 residues of the human proteins being identical. Some evidence exists that there are limited sequence differences in the AFP of a given animal species. AFP shows considerable charge heterogeneity that appears to relate mostly to its glycoid moiety. The proteins of some species such as the rat show more pronounced heterogeneities than that of humans. The variations in extent and type of glycosylations are evidenced by differences in the binding to various lectins. These interactions are being extensively explored in attempts to differentiate the sources of the protein produced by various normal and neoplastic cells and may provide valuable diagnostic methods. AFP, like serum albumin, shows relatively strong binding affinities for a variety of ligands. The most notable difference is the strong preferential binding of polyunsaturated fatty acids by AFP. This protein may play a role in transporting these substances to developing and to malignant cells. Various agents affect the synthesis of this protein both by specific fetal tissues and by neoplastic cells. Marked differences in the responses of cells, particularly those of neoplastic types, are indicative of variations in the genetic factors responsible for control of its synthesis. The subject of the genomic repression of the synthesis of AFP seen in fetal life upon maturation of the liver and the reoccurrence of synthesis upon malignant conversion of hepatocytes and of certain germ cells are of particular interest. The regulation of the closely related AFP and albumin genes is providing a powerful and attractive model to examine molecular events in the activation and inactivation of specific genes during development and in oncogenic processes. Extensive measurements of AFP during pregnancy and in the course of neoplasias, notably hepatoma, are being made to aid in following changes in such developments. Various specific physiological roles for this protein are also being proposed. One of these is its possible action in the regulation of immune processes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709334     DOI: 10.1016/s0065-230x(08)60483-2

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  25 in total

1.  The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).

Authors:  Mei-Chuan Huang; Kelly Ke Li; Brett T Spear
Journal:  DNA Cell Biol       Date:  2002-08       Impact factor: 3.311

2.  Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.

Authors:  R Moro; J Gulyaeva-Tcherkassova; P Stieber
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

3.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

4.  Glycoproteins identified from heart failure and treatment models.

Authors:  Shuang Yang; Lijun Chen; Shisheng Sun; Punit Shah; Weiming Yang; Bai Zhang; Zhen Zhang; Daniel W Chan; David A Kass; Jennifer E van Eyk; Hui Zhang
Journal:  Proteomics       Date:  2014-10-09       Impact factor: 3.984

5.  Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility.

Authors:  Philippe Gabant; Lesley Forrester; Jennifer Nichols; Thierry Van Reeth; Christelle De Mees; Bernard Pajack; Alistair Watt; Johan Smitz; Henri Alexandre; Claude Szpirer; Josiane Szpirer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

6.  Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.

Authors:  Meng-Sen Li; Qiu-Ling Ma; Qian Chen; Xin-Hua Liu; Ping-Feng Li; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

7.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

8.  Biomarker identification of hepatocellular carcinoma using a methodical literature mining strategy.

Authors:  Nai-Wen Chang; Hong-Jie Dai; Yung-Yu Shih; Chi-Yang Wu; Mira Anne C Dela Rosa; Rofeamor P Obena; Yu-Ju Chen; Wen-Lian Hsu; Yen-Jen Oyang
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

9.  Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.

Authors:  Annekatrin Lukanova; Ritu Andersson; Marianne Wulff; Anne Zeleniuch-Jacquotte; Kjell Grankvist; Laure Dossus; Yelena Afanasyeva; Robert Johansson; Alan A Arslan; Per Lenner; Göran Wadell; Göran Hallmans; Paolo Toniolo; Eva Lundin
Journal:  Am J Epidemiol       Date:  2008-10-20       Impact factor: 4.897

10.  Gene cloning of murine alpha-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cells.

Authors:  Jilin Yi; Geng Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.